91 related articles for article (PubMed ID: 11579826)
1. [The assessment of nutritional status in children with chronic hepatitis B treated with interferon alpha].
Lebensztejn DM; Zagórecka E; Kaczmarski M; Piotrowska-Jastrzebska J
Pol Merkur Lekarski; 2001 Jul; 11(61):29-31. PubMed ID: 11579826
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
Choe BH; Lee JH; Jang YC; Jang CH; Oh KW; Kwon S; Hyun MC; Ko CW; Lee KS; Lee WK
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
[TBL] [Abstract][Full Text] [Related]
4. [Thyroid function in children with diagnosed chronic hepatitis B treated with interferon alpha].
Lebensztejn DM; Kaczmarski M; Wysocka J; Lipska A
Pol Merkur Lekarski; 2000 Jun; 8(48):378-80. PubMed ID: 10967911
[TBL] [Abstract][Full Text] [Related]
5. [The HBeAg/antiHBe seroconversion as a result of lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy].
Lebensztejn DM; Skiba E; Sobaniec-Lotowska M; Kaczmarski M
Pol Merkur Lekarski; 2004 Jun; 16(96):557-9. PubMed ID: 15510896
[TBL] [Abstract][Full Text] [Related]
6. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
[TBL] [Abstract][Full Text] [Related]
7. Interferon treatment in children with chronic hepatitis B: an Israeli experience.
Hartman C; Hager H; Berkowitz D; Rimon N; Bassan L; Trogouboff P; Teitler A; Shamir R
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):914-8. PubMed ID: 12455179
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.
Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P
Acta Virol; 2001; 45(5-6):293-7. PubMed ID: 12083328
[TBL] [Abstract][Full Text] [Related]
10. Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study.
D'Antiga L; Aw M; Atkins M; Moorat A; Vergani D; Mieli-Vergani G
J Pediatr; 2006 Feb; 148(2):228-233. PubMed ID: 16492434
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the somatic development in children with chronic virus hepatitis].
Kupś J; Wozniakowska-Gesicka T; Wiśniewska-Ligier M; Kubacki J
Pol Merkur Lekarski; 2005 Jun; 18(108):637-41. PubMed ID: 16124373
[TBL] [Abstract][Full Text] [Related]
12. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
Kuloglu Z; Krsaçloglu CT; Kansu A; Erden E; Girgin N
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
[TBL] [Abstract][Full Text] [Related]
13. Tolerance of interferon-alpha therapy in children with chronic hepatitis B.
Liberek A; Łuczak G; Korzon M; Szlagatys-Sidorkiewicz A; Bako W; Góra-Gebka M; Rytlewska M; Sikorska-Wiśniewska G
J Paediatr Child Health; 2004; 40(5-6):265-9. PubMed ID: 15151579
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic hepatitis with interferon in children with kidney diseases].
Szczepańska M; Tobis A; Schneiberg B; Szprynger K; Kobos E; Morawiec-Knysak A
Pol Merkur Lekarski; 2005 Jan; 18(103):22-8. PubMed ID: 15859541
[TBL] [Abstract][Full Text] [Related]
16. Influences of different therapy protocols for chronic hepatitis B infection in Turkish children on nutritional anthropometric data.
Ozturk Y; Arli AO; Arslan N; Bekem O; Hizli S; Buyukgebiz B
J Health Popul Nutr; 2004 Dec; 22(4):443-4. PubMed ID: 15663178
[No Abstract] [Full Text] [Related]
17. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
19. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation of hyaluronic acid and laminin concentration in serum in children with chronic hepatitis B treated with lamivudine, unresponsive to previous interferon-alpha therapy].
Skiba E; Lebensztejn DM; Werpachowska I; Kaczmarski M
Pol Merkur Lekarski; 2005 Mar; 18(105):268-70. PubMed ID: 15997629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
